OMERS Administration Corp’s Bio-Rad Laboratories Class A BIO Stock Holding History

OMERS Administration Corp’s Portfolio BIO Stock Details BIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$213K	Hold	765	–	–	﹤0.01%	907
2025 Q4	$232K	Hold	765	–	–	﹤0.01%	880
2025 Q3	$214K	Buy	+765	New	+$208K	﹤0.01%	965
2025 Q1	–	Sell	-890	Closed	-$292K	–	1035
2024 Q4	$292K	Buy	890 +138	+18%	+$46.8K	﹤0.01%	822
2024 Q3	$252K	Hold	752	–	–	﹤0.01%	771
2024 Q2	$205K	Buy	+752	New	+$219K	﹤0.01%	883
2019 Q2	–	Sell	-8,900	Closed	-$2.82M	–	394
2019 Q1	$2.82M	Buy	+8,900	New	+$2.4M	0.03%	121
2015 Q2	–	Sell	-11,700	Closed	-$1.58M	–	428
2015 Q1	$1.58M	Buy	+11,700	New	+$1.45M	0.06%	169

Other funds holding BIO

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

OMERS Administration Corp's BIO Position: Q1 2026 in Review

OMERS Administration Corp held its Bio-Rad Laboratories Class A (BIO) position steady in Q1 2026 at 765 shares worth $213K. The position accounts for ﹤0.01% of the portfolio, ranked #907.

OMERS Administration Corp first reported a position in BIO in Q1 2015 and has held it in 8 quarters since. The position peaked at $2.82M in Q1 2019. 391 funds tracked by Wall St. Rank hold BIO as of Q1 2026.

OMERS Administration Corp held 765 shares of Bio-Rad Laboratories Class A worth $213K as of Q1 2026.
OMERS Administration Corp left its Bio-Rad Laboratories Class A share count unchanged in Q1 2026.
Bio-Rad Laboratories Class A made up ﹤0.01% of OMERS Administration Corp's portfolio in Q1 2026, its #907 holding.
OMERS Administration Corp first reported a position in Bio-Rad Laboratories Class A in Q1 2015 and has held it in 8 quarters since.
OMERS Administration Corp's Bio-Rad Laboratories Class A position peaked at $2.82M in Q1 2019.
391 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q1 2026.

Based on OMERS Administration Corp's 13F filing for Q1 2026, filed 15 May 2026.